Diabetes and Wound Angiogenesis.
Okonkwo UA, DiPietro LA. · 2017
Read Diabetes and Wound Angiogenesis. by Okonkwo UA, DiPietro LA. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5535911.txt.
Introduction
Okonkwo and DiPietro review how diabetes harms new blood vessel growth in healing skin wounds. Their article appeared in the International Journal of Molecular Sciences. Type 2 diabetes slows healing at each stage of repair. Foot ulcers are a common result, and some lead to loss of a limb.
Healthy wounds grow fresh capillaries in set steps, then reshape and mature them. In diabetes, those steps go wrong, the authors explain. Vessel walls, support cells, and growth signals all fail in part. The review tracks faults in the growth, reshaping, and maturing phases. It also weighs treatments that aim to restore blood flow and help wounds close.
Catalog record
| CREATOR | Okonkwo UA, DiPietro LA. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Diabetes and Wound Angiogenesis By Uzoagu A. Okonkwo, Luisa A. DiPietro Published in: International Journal of Molecular Sciences DOI: 10.3390/ijms18071419 ABSTRACT Diabetes Mellitus Type II (DM2) is a growing international health concern with no end in sight. Complications of DM2 involve a myriad of comorbidities including the serious complications of poor wound healing, chronic ulceration, and resultant limb amputation. In skin wound healing, which has definite, orderly phases, diabetes leads to improper function at all stages. While the etiology of chronic, non-healing diabetic wounds is multi-faceted, the progression to a non-healing phenotype is closely linked to poor vascular networks. This review focuses on diabetic wound healing, paying special attention to the aberrations that have been described in the proliferative, remodeling, and maturation phases of wound angiogenesis. Additionally, this review considers therapeutics that may offer promise to better wound healing outcomes. 1. INTRODUCTION Diabetes mellitus type II (DM2) is a metabolic disorder defined by hyperglycemia due to insulin resistance. DM2 has become a major global health epidemic with a particularly large incidence in the United States. As of 2010 the global prevalence of DM2 was estimated at 280 million people, with recent measures by the Centers for Disease Control and Prevention (CDC) in 2014 indicating that 86 million Americans are in the pre-diabetic state and 29.1 million have been diagnosed with the disease [1]. DM2 is associated with numerous co-morbidities, including, but not limited to, cardiovascular disease, stroke, chronic renal failure, peripheral neuropathy, and diabetic skin wounds or ulcerations [2]. Diabetic skin ulcerations present as painful sores with disintegration of dermal tissue including the epidermis, dermis, and in many cases, subcutaneous tissue [3]. In diabetes, chronic skin ulcerations are common on the lower extremities, particularly the foot. Diabetic foot ulcers (DFU) affect 15% of diabetic patients. Of those patients with DFUs, 14–24% subsequently experience a lower extremity amputation, with the mortality rate from amputation approaching 50–59% five-year post-amputation [3,4,5,6]. Studies of the pathology of diabetic foot ulceration have focused on microbial invasion, epithelial breakdown, and impaired immune function as some of the causative factors for the non-healing phenotype [7]. One underlying factor that accompanies all diabetic ulcerations is poor vascular flow, a circumstance that impedes proper wound healing. Numerous studies have highlighted the importance of adequate vascular sufficiency and vessel proliferation in tissue repair and the lack thereof in diabetic wound healing [8]. More studies, albeit limited, have looked at whether disarrayed capillary remodeling and maturation of vessels might play a role in impaired diabetic wound healing. This review will synthesize the current findings in the literature about the role of appropriate capillary growth, function, and maturation in the context of diabetic wound healing. 2. THE ANATOMY AND MAINTENANCE OF BLOOD VESSELS The human body is composed of a vast network of blood vessels that receive nutrient-rich, oxygenated blood from the heart starting with the largest in size called arteries, then subsequently decreasing in diameter to the arteriole, and finally to the capillary, where actual gas, nutrient, and waste exchange between vessels and tissue occurs. Waste is then carried back to the great veins of the venous system through venules. Capillaries, the cornerstone of nutrient diffusion, are so abundant in the body that no cell is more than 100–200 microns from one [9]. The anatomy of a capillary can be described as a microvessel that is composed of a one-cell layer thick lumen of endothelium with a diameter of 8–20 microns, just wide enough for the flow of erythrocytes and leukocytes [10]. The endothelial cells (EC) that constitute capillaries are dynamic cell types that have only recently been appreciated for their many activities. Endothelial cells line the lumen of every blood vessel in the body and are involved in filtration, hemostasis, barrier function, inflammation, and angiogenesis [11]. In the unwounded state, endothelial cells lining vessels are in a setting of quiescence demonstrated by the mostly basal expression of pro or anti-angiogenic stimuli in the vascular bed [12]. At the level of the capillaries, endothelial cells are in an intimate relationship with an enigmatic cell type called the pericyte. The pericyte is a type of mural cell embedded in the vascular basement membrane that wraps around endothelial cells [13,14]. Much remains to be discovered about this cell. Studies suggest that pericytes participate in regulation of capillary blood flow, clearance of cellular debris, stabilization, and paracrine communication of endothelial cells [15,16,17]. Loss of pericytes perturbs capillary function and results in extravascular leakage and edema [18]. The clear-cut identification of pericytes has long been a source of consternation. Due to their morphological similarities to vascular smooth muscle, the detection of distinct and ubiquitous markers that identify the unique pericyte population in vessels has proved to be an arduous task. Markers used with some success include α-smooth muscle actin (α-SMA) neural/glial antigen-2 (NG-2), desmin, Regulator of G-protein signaling 5 (RGS5), and platelet-derived growth factor receptor (PDGFR)-β [15,19]. Unfortunately, none of these markers are truly specific for the pericyte, and each marker is known to be expressed in other cell types. Nonetheless, several studies have linked some of these markers with pericyte function. Of note, PDGFR-β has been shown to be responsible for the recruitment of pericytes, and inhibition of PDGFR-β by imantinib results in decreased pericyte recruitment and migration in vitro [20]. In a mouse model, imantinib treatment caused decreased levels of NG-2+ pericytes in dermal wound tissue [21]. The role of PDGFR-β derives from interaction with its ligand, PDGF-β. PDGF-β deficient embryos show insufficient mural cell recruitment, resulting in uncontrolled EC development, vessel enlargement, permeability, and impaired perfusion [22,23]. Other factors that have been implicated in the maintenance of pericytes include the endothelial cell receptor, angiopoietin-2 receptor (Tie2) and its ligand, angiopoietin-1 (Ang1). Many studies showcase the importance of the Tie2/Ang1 complex to vessel maturity and integrity, including down regulation of the pro-angiogenic factor vascular endothelial growth factor (VEGF), and in turn, prevention of vascular leakage [24,25]. 3. VASCULOGENESIS AND ANGIOGENESIS Vasculogenesis is defined as the formation of new vessels from precursor cells that coalesce into primitive vascular networks. This process, which is prominent during development, contrasts with angiogenesis, which is the formation of new capillaries from established vasculature [26]. Angiogenesis occurs primarily during embryonic and post-natal development and is quite rare in the healthy adult state except in the female reproductive system [27]. Several female reproductive organs, including the ovary, endometrial lining of the uterus, and placenta undergo angiogenesis as part of their normal physiologic responses [28]. Both physiologic and pathologic angiogenesis are regulated by a balance of proangiogenic factors and anti-angiogenic factors. Vessels produced during non-pathologic angiogenesis are characterized by their refinement, integrity, and ability to deliver nutrients to tissues in a controlled, timely manner [29]. Disarrayed, runaway angiogenesis is a distinguishing feature of many pathologic processes including solid tumor growth and fibrosis [29,30]. In such pathological disease states, angiogenesis can be persistent, disorganized, and never reaches attenuation [31,32]. While basal levels of pro-angiogenic factors and the expression of their corresponding receptors are maintained during the healthy state of homeostasis, the diseased state exhibits upregulated expression of pro-angiogenic factors such as VEGF, fibroblast growth factor (FGF), and others to promote unfettered growth of vessel beds and continual proliferation and migration of endothelial